CRYOPAK CII.V Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : CRYOPAK CII.V

CII 23.25

+0.4%

Dec 5 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Judi Simpson who wrote (293)	1/29/2001 1:16:17 PM
From: Brister	of 298

GlaxoSmithKline Retains Cryopak for Cold-Chain Management Consulting CYPKF (NASD OTCBB) / CII (CDNX) VANCOUVER, Jan. 29 /CNW/ - Cryopak Industries Inc. (CYPKF: OTCBB and CII: CDNX) is pleased to announce that it has been retained by GlaxoSmithKline (GSK) to act in a consulting capacity to optimize the pharmaceutical company's cold-chain management program. Headquartered in the UK and with operations based in the US, GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with an estimated seven per cent of the world's pharmaceutical market. GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products. For more information about GSK, please view their web site at www.gsk.com. Cryopak Industries Inc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next